Induced Native Phage Therapy for the Treatment of Lyme Disease and Relapsing Fever: A Retrospective Review of First 14 Months in One Clinic

The overall failure rate of standard therapeutic options for late/chronic/persistent borreliosis emphasizes the need for novel therapeutic strategies. In this report, we are presenting a novel therapeutic option based on a new technology, Induced Native Phage Therapy (INPT; PhagenCorp, LLC, Sarasota...

Descripción completa

Detalles Bibliográficos
Autores principales: Jernigan, David A, Hart, Martin C, Dodd, Keeley K, Jameson, Samuel, Farney, Todd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Infectious Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636187/
https://www.ncbi.nlm.nih.gov/pubmed/34873551
http://dx.doi.org/10.7759/cureus.20014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636187/
https://www.ncbi.nlm.nih.gov/pubmed/34873551
http://dx.doi.org/10.7759/cureus.20014

Ejemplares similares